Search Results 171-180 of 16309 for Alirocumab

  1. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

    The primary objective is to estimate the overall response rate (ORR) for metastatic Basal Cell Carcinoma (BCC) (group 1) and for unresectable locally advanced ...

  2. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

    About this study. Primary Objective: To demonstrate the benefit of isatuximab in combination with pomalidomide and low-dose dexamethasone in the ...

  3. Olutasidenib (oral route) - Side effects & dosage - Mayo Clinic

    Olutasidenib is used to treat acute myeloid leukemia in patients with a susceptible isocitrate dehydrogenase-1 (IDH-1) mutation that has come back or has not ...

  4. Osimertinib (oral route) - Side effects & dosage - Mayo Clinic

    Osimertinib is used to treat non-small cell lung cancer (NSCLC) in patients who have certain types of abnormal epidermal growth factor (EGFR) genes. This ...

  5. Clinical trials - Oncology (Medical)

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  6. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  8. Early Access Program With Arimoclomol in US Patients With NPC - Mayo Clinic

    NPC is a rare, relentlessly progressive, neurological disease and associated with serious morbidity and shortened life expectancy. Participants will receive ...

  9. Tildrakizumab-asmn (subcutaneous route) - Side effects & uses - Mayo Clinic

    Tildrakizumab-asmn injection is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away ...

  10. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

    This randomized pilot trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain ...